Friday, 19 August 2022

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

The U.S. Food and Drug Administration (FDA) has ordered Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday.

John Hancock in $26.3 million settlement with New York over canceled insurance policies

John Hancock Life & Health Insurance Co will pay $26.3 million to settle a New York probe that found it prematurely terminated long-term care policies before policyholders, many now dead, exhausted their benefits.

Fresenius SE CEO to quit after earnings outlook sours

Fresenius SE said its long-serving Chief Executive Stephan Sturm would quit, to be replaced by the head of its drugs unit, after the diversified group's earnings were hit following the COVID pandemic and a surge in costs.

Canada OKs Pfizer COVID booster for kids 5-11, sees monkeypox cases slow

Canada's health ministry on Friday said it had authorized the use of Pfizer Inc's and BioNTech's COVID-19 vaccine as a booster for children five to 11 years old at least six months after receiving their initial two doses.

EU backs changing monkeypox vaccine injection method to boost supply

European countries could stretch out limited supplies of the monkeypox vaccine by administering smaller doses of the shot, the European Medicines Agency (EMA) said on Friday.

Axsome's depression drug enters competitive market after U.S. approval

Axsome Therapeutics Inc on Friday gained U.S. approval for its treatment for depression, giving more than 20 million Americans affected by the disorder a new option in a market crowded by older drugs.

WHO recommends use of two antibody drugs against Ebola

The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against Ebola, saying the use of such drugs combined with better care had "revolutionised" the treatment of a disease once seen as a near-certain killer.

Britain faces 'humanitarian crisis' as energy costs soar, says health lobby

Britain faces a "humanitarian crisis" this winter when the difficult choices forced upon low-income households by soaring energy bills could cause serious physical and mental illness, a healthcare lobby group said on Friday.

North Korea's Kim praises military medics for frontline COVID fight in capital

North Korean leader Kim Jong Un held a ceremony to thank and praise military medics for spearheading the country's fight against the coronavirus in the capital Pyongyang, state media said on Friday.

Abortion drug maker drops challenge to Mississippi ban

A manufacturer of mifepristone, a drug used in medication abortions, on Thursday dropped its legal fight to sell the drug in Mississippi after the state banned nearly all abortions.

Related Videos

Why has polio returned to the United States?

Mobile fridges keep vaccines cool in Kenya

Mobile fridges keep vaccines cool in Kenya